NYSE:ZBH - Zimmer Biomet Stock Price, Forecast & News

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Zimmer Biomet declared a quarterly dividend on Monday, December 16th. Investors of record on Friday, December 27th will be paid a dividend of $0.24 per share on Friday, January 31st. This represents a $0.96 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date is Thursday, December 26th. View Zimmer Biomet's Dividend History.

Zimmer Biomet Holdings Inc (NYSE:ZBH) announced its quarterly earnings data on Tuesday, February, 4th. The medical equipment provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.03. The medical equipment provider earned $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. Zimmer Biomet had a net margin of 14.18% and a return on equity of 13.64%. The company's revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the company posted $2.18 EPS. View Zimmer Biomet's Earnings History.

Zimmer Biomet is scheduled to release their next quarterly earnings announcement on Friday, April 24th 2020. View Earnings Estimates for Zimmer Biomet.

Zimmer Biomet updated its FY20 earnings guidance on Tuesday, February, 4th. The company provided EPS guidance of $8.15 to $8.45 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.29. The company issued revenue guidance of $8.18 billion to $8.26 billion, compared to the consensus revenue estimate of $8.16 billion.

26 equities research analysts have issued 1 year price targets for Zimmer Biomet's stock. Their forecasts range from $121.71 to $190.00. On average, they anticipate Zimmer Biomet's stock price to reach $161.76 in the next twelve months. This suggests a possible upside of 0.8% from the stock's current price. View Analyst Price Targets for Zimmer Biomet.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last year. There are currently 1 sell rating, 3 hold ratings, 20 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Zimmer Biomet.

News articles about ZBH stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Zimmer Biomet earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Zimmer Biomet.

Some companies that are related to Zimmer Biomet include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Smith & Nephew (SNN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX) and Invacare (IVC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Cisco Systems (CSCO), Walt Disney (DIS), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Home Depot (HD), Visa (V), Intel (INTC) and Verizon Communications (VZ).

Zimmer Biomet's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Massachusetts Financial Services Co. MA (5.20%), State Street Corp (4.13%), Boston Partners (2.04%), Amundi Pioneer Asset Management Inc. (1.25%), Ceredex Value Advisors LLC (1.14%) and Bank of New York Mellon Corp (0.95%). Company insiders that own Zimmer Biomet stock include Arthur J Higgins, Aure Bruneau, Betsy J Bernard, Bryan C Hanson, Chad F Phipps, Didier Deltort, Katarzyna Mazur-Hofsaess, Michael J Farrell, Michael W Michelson, Sang Yi, Syed A Jafry and Tony W Collins. View Institutional Ownership Trends for Zimmer Biomet.

ZBH stock was sold by a variety of institutional investors in the last quarter, including Partner Fund Management L.P., Massachusetts Financial Services Co. MA, Snow Capital Management LP, Panagora Asset Management Inc., Wedge Capital Management L L P NC, Cubist Systematic Strategies LLC, Ceredex Value Advisors LLC and SG Americas Securities LLC. Company insiders that have sold Zimmer Biomet company stock in the last year include Aure Bruneau, Chad F Phipps, Didier Deltort and Sang Yi. View Insider Buying and Selling for Zimmer Biomet.

ZBH stock was acquired by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., FMR LLC, Boston Partners, UBS Asset Management Americas Inc., Anchor Capital Advisors LLC, State Street Corp, Alleghany Corp DE and Marshall Wace LLP. Company insiders that have bought Zimmer Biomet stock in the last two years include Arthur J Higgins, Betsy J Bernard, Bryan C Hanson, Michael J Farrell, Michael W Michelson and Syed A Jafry. View Insider Buying and Selling for Zimmer Biomet.

Shares of ZBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ZBH stock can currently be purchased for approximately $160.40.

Zimmer Biomet has a market capitalization of $32.99 billion and generates $7.98 billion in revenue each year. The medical equipment provider earns $1.13 billion in net income (profit) each year or $7.87 on an earnings per share basis. Zimmer Biomet employs 19,000 workers across the globe.View Additional Information About Zimmer Biomet.

The official website for Zimmer Biomet is http://www.zimmerbiomet.com/.

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The medical equipment provider can be reached via phone at 574-267-6131 or via email at [email protected]